Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae:: characterization of South African isolates

被引:51
作者
Klugman, KP
Capper, T
Widdowson, CA
Koornhof, HJ
Moser, W
机构
[1] S African Inst Med Res, MRC SAIMR WITS Pneumococcal Dis Res Unit, ZA-2000 Johannesburg, South Africa
[2] Biochem GmbH, A-6250 Kundl, Austria
关键词
D O I
10.1093/jac/42.6.729
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibility of 40 erythromycin-resistant isolates of Streptococcus pyogenes and 40 multiply-resistant isolates of Streptococcus pneumoniae to six macrolide antibiotics, representing 14-, 15- and 16-membered lactone ring structures, was tested. The genetic basis for macrolide resistance in the strains was also determined. Both erm and mef determinants were encountered in the 36 S. pneumoniae Isolates tested, but only mef in the five S. pyogenes isolates tested. All isolates showed cross-resistance among the 14-membered macrolides erythromycin, clarithromycin and roxithromycin and the 15-membered macrolide, azithromycin. However, the erythromycin-resistant S pyogenes isolates retained full susceptibility to spiramycin and josamycin (16-membered agents). These latter two antibiotics were also more active than the other macrolides against erythromycin-resistant S. pneumoniae isolates, especially josamycin which was 8-64 times more active than erythromycin; spiramycin was only two to eight times more active than erythromycin.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 26 条
[1]   ACTIVITY OF A-56268 COMPARED WITH THAT OF ERYTHROMYCIN AND OTHER ORAL-AGENTS AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, NM ;
LABTHAVIKUL, P ;
SAHA, G ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) :463-466
[2]   Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study [J].
Doern, GV ;
Brueggemann, A ;
Holley, HP ;
Rauch, AM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1208-1213
[3]  
EMOND JP, 1989, PATHOL BIOL, V37, P791
[4]  
FINCH R, 1993, BRIT J HOSP MED, V49, P346
[5]   CLINICAL EFFICACY AND TOLERANCE OF 2 NEW MACROLIDES, CLARITHROMYCIN AND JOSAMYCIN, IN THE TREATMENT OF PATIENTS WITH ACUTE EXACERBATIONS OF CHRONIC-BRONCHITIS [J].
FRASCHINI, F .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1990, 18 (02) :171-176
[6]   COMPARATIVE INVITRO ACTIVITIES OF NEW 14-MEMBERED, 15-MEMBERED, AND 16-MEMBERED MACROLIDES [J].
HARDY, DJ ;
HENSEY, DM ;
BEYER, JM ;
VOJTKO, C ;
MCDONALD, EJ ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1710-1719
[7]   SUSCEPTIBILITY OF GROUP-A BETA-HEMOLYTIC STREPTOCOCCUS ISOLATES TO PENICILLIN AND ERYTHROMYCIN [J].
ISTRE, GR ;
WELCH, DF ;
MARKS, MI ;
MOYER, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (02) :244-246
[8]  
KALEIDA PH, 1991, PEDIATRICS, V87, P466
[9]  
KERNBAUM S, 1982, SEM HOP PARIS, V58, P289
[10]   MANAGEMENT OF ANTIBIOTIC-RESISTANT PNEUMOCOCCAL INFECTIONS [J].
KLUGMAN, KP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (02) :191-193